Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Pietrucha

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Frontiers in Pediatrics|June 6, 2022
BCG Moreau Polish Substrain Infections in Patients With Inborn Errors of Immunity: 40 Years of Experience in the Department of Immunology, Children's Memorial Health Institute, WarsawEwa Bernatowska, Małgorzata Pac, Edyta Heropolitańska-Pliszka, et al.
Frontiers in Neurology|February 7, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasiaMary Kay Koenig, Vincenzo Leuzzi, Riadh Gouider, et al.
Journal of Clinical Immunology|November 22, 2019
BCG Moreau Vaccine Safety Profile and NK Cells-Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined ImmunodeficiencyEwa Bernatowska, Małgorzta Skomska-Pawliszak, Beata Wolska-Kuśnierz, et al.
The Lancet. Neurology|August 16, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trialStefan Zielen, Thomas Crawford, Luca Benatti, et al.
Journal of Clinical Immunology|August 15, 2015
Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective AnalysisBeata Wolska-Kuśnierz, Hanna Gregorek, Krystyna Chrzanowska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage SyndromeBeata Wolska-Kusnierz, Agata Pastorczak, Wojciech Fendler, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndromeCristina Woellner, E Michael Gertz, Alejandro A Schäffer, et al.
Journal of Clinical Immunology|September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-TelangiectasiaStefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
Medicine|November 9, 2010
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countriesLudovic de Beaucoudrey, Arina Samarina, Jacinta Bustamante, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Frontiers in Pediatrics|June 6, 2022
BCG Moreau Polish Substrain Infections in Patients With Inborn Errors of Immunity: 40 Years of Experience in the Department of Immunology, Children's Memorial Health Institute, WarsawEwa Bernatowska, Małgorzata Pac, Edyta Heropolitańska-Pliszka, et al.
Frontiers in Neurology|February 7, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasiaMary Kay Koenig, Vincenzo Leuzzi, Riadh Gouider, et al.
Journal of Clinical Immunology|November 22, 2019
BCG Moreau Vaccine Safety Profile and NK Cells-Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined ImmunodeficiencyEwa Bernatowska, Małgorzta Skomska-Pawliszak, Beata Wolska-Kuśnierz, et al.
The Lancet. Neurology|August 16, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trialStefan Zielen, Thomas Crawford, Luca Benatti, et al.
Journal of Clinical Immunology|August 15, 2015
Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective AnalysisBeata Wolska-Kuśnierz, Hanna Gregorek, Krystyna Chrzanowska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2020
Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage SyndromeBeata Wolska-Kusnierz, Agata Pastorczak, Wojciech Fendler, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndromeCristina Woellner, E Michael Gertz, Alejandro A Schäffer, et al.
Journal of Clinical Immunology|September 3, 2021
Simple Measurement of IgA Predicts Immunity and Mortality in Ataxia-TelangiectasiaStefan Zielen, Ruth Pia Duecker, Sandra Woelke, et al.
Medicine|November 9, 2010
Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countriesLudovic de Beaucoudrey, Arina Samarina, Jacinta Bustamante, et al.
Pageof 4